ESC Guidelines for the management of Stable Coronary Artery Disease, engl.

Year of publication: 2013

Editing medical society(ies):
European Society of Cardiology (ESC),
Deutsche Gesellschaft für Kardiologie - Herz- und Kreislaufforschung e.V. (DGK)

Other medical societies involved: 18

ESC Guidelines


List of evaluated guidelines

Evaluation by Leitlinienwatch

22.05.16


PTs.

Criterion
2

Transparency

European Society of Cardiology (ESC) guideline outside the German AWMF guideline register (http://eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf). Detailed information regarding conflicts of interest for each author is published on the ESC homepage. (https://www.escardio.org/static_file/Escardio/Guidelines/SCAD_DOI.pdf)
There is no transparent evaluation of conflicts of interest as part of the guideline process.
0

Composition of the Guideline Working Group

19 out of 24 authors in the guideline working group declared financial conflicts of interest.
0

Independence of the Coordinators/Chairs/Lead AuthorsUnabhängigkeit der Vorsitzenden/federführenden Autoren

Both lead authors declared financial conflicts of interest.
0

Abstention from Voting

There is no documented rule regarding abstention.
0

External Review of the Guideline

An external review via a publicly accessible website did not occur; only an internal review took place (see below).
1

Bonus Points

1 bonus point for internal review by 21 reviewers selected by the ESC. These reviewers also declared their conflicts of interest. (ESC Committee for Practice Guidelines (CPG))

Explanations to the evaluation criteria

Overall score

3

Good! (11-18)

Warning! (6-10)

Needs reform! (0-5)

Comment

The ESC guidelines also apply in Germany, as the Deutsche Gesellschaft für Kardiologie (German Society of Cardiology) publishes a pocket guideline entitled “Management der stabilen koronaren Herzkrankheit (KHK)” (“Management of Stable Coronary Artery Disease”) that is based on the ESC guidelines. The guidelines classify drug therapies, examinations with large medical equipment (cardio CT, stress MRI), and invasive procedures with implants (coronary angiography, stent implantation), some of which are costly. The majority of ESC guideline authors declare financial conflicts of interest involving the manufacturers of these products. A standard guideline report that would explain the study evaluation methods, recruitment of the guideline working group, evaluations of conflicts of interest and the measures derived from those evaluations (such as rules regarding abstention from voting) is not provided.

Note: This evaluation was conducted with due care on the basis of the published guideline. Should you still discover an error, please contact us at info@leitlinienwatch.de.